Mission MSA schedules virtual patient forum on multiple system atrophy

Mission MSA, a non-profit organization focused on multiple system atrophy (MSA), will conduct a virtual forum on March 16, 2027, to gather direct testimony from those affected by the disease. The initiative aims to provide stakeholders and developers with critical insights into the patient experience to guide future treatment research.

MSA is a rare, progressive neurodegenerative disorder that currently lacks curative therapies. By facilitating a patient-focused drug development session, Mission MSA intends to document the specific challenges patients face, which will assist researchers in identifying unmet needs and defining endpoints for clinical trials.

The virtual session is free and open to patients and their caregivers. Findings from the meeting will be compiled to serve as a resource for the broader medical community as they work to address the symptoms and progression of the disease.